Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1999-03-19
2000-07-04
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424405, 424439, 426 71, 426648, 426658, 426801, A01N 4304, A61K 31715
Patent
active
060839341
ABSTRACT:
A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
REFERENCES:
patent: 4851338 (1989-07-01), Mardh et al.
patent: 4919961 (1990-04-01), Lundblad
patent: 5288637 (1994-02-01), Roth
patent: 5700671 (1997-12-01), Prieto et al.
patent: 5906982 (1999-05-01), Prieto et al.
Beerens et al. Am. J. Clin. Nutrit. vol. 33, pp. 2434-2439, 1980.
Petschow et al. J. Clin. Microbiol. vol. 28, pp. 287-292, 1990.
J. Sambrook et al., Molecular Cloning: A Laboratory Manual, 2.sup.nd Edition, Cold Spring Harbor Laboratory Press (1989).
B. W. Petschow et al., "Growth Promotion of Bifidobacterium Species by Whey and Casein Fractions From Human and Bovine Milk", Journal of Clinical Microbiology, Feb., (1990), pp. 287-292.
H. Beerens et al., "Influence of Breast-Feeding on the Bifid Flora of the Newborn Intestine", The American Journal of Clinical Nutrition, vol. 33, (1980), pp. 2434-2439.
Kroening Terry A.
Prieto Pedro A.
Abbott Laboratories
Becker Cheryl L.
Lankford , Jr. Leon B.
Tate Christopher R.
LandOfFree
Nutritional formulations containing lacto-N-neotetraose does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional formulations containing lacto-N-neotetraose, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional formulations containing lacto-N-neotetraose will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486727